Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial-Reference-Cited by-同舟云学术

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

Published:2006-02 Issue:2 Volume:64 Page:518-526
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pollack Alan,Hanlon Alexandra L.,Horwitz Eric M.,Feigenberg Steven J.,Konski Andre A.,Movsas Benjamin,Greenberg Richard E.,Uzzo Robert G.,Ma C.-M. Charlie,McNeeley Shawn W.,Buyyounouski Mark K.,Price Robert A.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference54 articles.

1. Fractionation and protraction for radiotherapy of prostate carcinoma;Brenner;Int J Radiat Oncol Biol Phys,1999

2. Is the prostrate alpha/beta ratio of 1.5 from Brenner & Hall a modeling artifact;King;Int J Radiat Oncol Biol Phys,2000

3. Is the alpha/beta ratio for prostate cancer low?;D’Souza;Int J Radiat Oncol Biol Phys,2001

4. Is alpha/beta for prostate tumors really low?;Fowler;Int J Radiat Oncol Biol Phys,2001

5. A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low;King;Int J Radiat Oncol Biol Phys,2001

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Prostate Cancer;Hypofractionated and Stereotactic Radiation Therapy;2024

3. A pooled patient‐reported outcomes analysis of moderately hypofractionated proton beam therapy and photon‐based intensity modulated radiation therapy for low‐ or intermediate‐risk prostate cancer;The Prostate;2023-12-18

4. A new target localization method for image-guided radiation therapy of prostate cancer;Physica Medica;2023-03

5. Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer;Pharmaceutics;2023-01-11